KR20150103285A - 피리미돈 유도체 및 바이러스 질환의 치료, 개선 또는 예방에서의 이의 용도 - Google Patents
피리미돈 유도체 및 바이러스 질환의 치료, 개선 또는 예방에서의 이의 용도 Download PDFInfo
- Publication number
- KR20150103285A KR20150103285A KR1020157021361A KR20157021361A KR20150103285A KR 20150103285 A KR20150103285 A KR 20150103285A KR 1020157021361 A KR1020157021361 A KR 1020157021361A KR 20157021361 A KR20157021361 A KR 20157021361A KR 20150103285 A KR20150103285 A KR 20150103285A
- Authority
- KR
- South Korea
- Prior art keywords
- mmol
- pyrimidine
- benzyloxy
- methyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003612 virological effect Effects 0.000 title claims abstract description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 30
- 201000010099 disease Diseases 0.000 title claims abstract description 26
- 238000011282 treatment Methods 0.000 title claims description 11
- 230000002265 prevention Effects 0.000 title claims description 6
- 150000008318 pyrimidones Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 239000013078 crystal Substances 0.000 claims abstract description 14
- 239000000651 prodrug Substances 0.000 claims abstract description 14
- 229940002612 prodrug Drugs 0.000 claims abstract description 14
- 239000012453 solvate Substances 0.000 claims abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
- -1 halogen atoms substituted Chemical class 0.000 claims description 339
- 239000000203 mixture Substances 0.000 claims description 230
- 150000001875 compounds Chemical class 0.000 claims description 161
- 238000000034 method Methods 0.000 claims description 102
- 206010057190 Respiratory tract infections Diseases 0.000 claims description 79
- 239000003112 inhibitor Substances 0.000 claims description 57
- 125000000217 alkyl group Chemical group 0.000 claims description 50
- 230000000694 effects Effects 0.000 claims description 29
- 206010022000 influenza Diseases 0.000 claims description 28
- 241000700605 Viruses Species 0.000 claims description 19
- 102100031780 Endonuclease Human genes 0.000 claims description 17
- 108010042407 Endonucleases Proteins 0.000 claims description 17
- 125000003118 aryl group Chemical group 0.000 claims description 17
- 239000003446 ligand Substances 0.000 claims description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 229940123066 Polymerase inhibitor Drugs 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 125000005842 heteroatom Chemical group 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 125000003107 substituted aryl group Chemical group 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 238000003556 assay Methods 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims description 5
- 239000003888 alpha glucosidase inhibitor Substances 0.000 claims description 5
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 241000711573 Coronaviridae Species 0.000 claims description 4
- 241000711950 Filoviridae Species 0.000 claims description 4
- 241000709664 Picornaviridae Species 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 4
- 101800004538 Bradykinin Proteins 0.000 claims description 3
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 3
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 claims description 3
- 241000712464 Orthomyxoviridae Species 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 3
- 229930003827 cannabinoid Natural products 0.000 claims description 3
- 239000003557 cannabinoid Substances 0.000 claims description 3
- 241000712892 Arenaviridae Species 0.000 claims description 2
- 241000712891 Arenavirus Species 0.000 claims description 2
- 241000710781 Flaviviridae Species 0.000 claims description 2
- 241000700586 Herpesviridae Species 0.000 claims description 2
- 241000711504 Paramyxoviridae Species 0.000 claims description 2
- 241000150350 Peribunyaviridae Species 0.000 claims description 2
- 241000711931 Rhabdoviridae Species 0.000 claims description 2
- 241000710924 Togaviridae Species 0.000 claims description 2
- 241001529453 unidentified herpesvirus Species 0.000 claims description 2
- 102100035792 Kininogen-1 Human genes 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000002648 combination therapy Methods 0.000 abstract description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 694
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 340
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 304
- 239000000243 solution Substances 0.000 description 296
- 235000019439 ethyl acetate Nutrition 0.000 description 233
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 224
- 239000007787 solid Substances 0.000 description 224
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 192
- 239000011541 reaction mixture Substances 0.000 description 170
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 153
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 124
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 116
- 238000006243 chemical reaction Methods 0.000 description 106
- 239000012043 crude product Substances 0.000 description 85
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 72
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 69
- 239000000741 silica gel Substances 0.000 description 69
- 229910002027 silica gel Inorganic materials 0.000 description 69
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 64
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 58
- 239000000377 silicon dioxide Substances 0.000 description 56
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 53
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 53
- 238000002360 preparation method Methods 0.000 description 53
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 51
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 50
- 239000012267 brine Substances 0.000 description 50
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 50
- 239000000047 product Substances 0.000 description 49
- 239000012044 organic layer Substances 0.000 description 47
- 230000002829 reductive effect Effects 0.000 description 47
- RILLZYSZSDGYGV-UHFFFAOYSA-N 2-(propan-2-ylamino)ethanol Chemical compound CC(C)NCCO RILLZYSZSDGYGV-UHFFFAOYSA-N 0.000 description 44
- 238000004587 chromatography analysis Methods 0.000 description 43
- 239000000725 suspension Substances 0.000 description 41
- 238000004809 thin layer chromatography Methods 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- QVGVOTGXLLTMAE-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]propan-2-amine Chemical compound CC(C)NCCO[Si](C)(C)C(C)(C)C QVGVOTGXLLTMAE-UHFFFAOYSA-N 0.000 description 35
- 239000002904 solvent Substances 0.000 description 34
- 239000007788 liquid Substances 0.000 description 33
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 32
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 31
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 229920006395 saturated elastomer Polymers 0.000 description 30
- 239000000284 extract Substances 0.000 description 29
- OEBDCBKRCYYLEM-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-2-[(2,3-dichlorophenyl)methyl]-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO[Si](C)(C)C(C)(C)C)C(C)C)=NC=1CC1=CC=CC(Cl)=C1Cl OEBDCBKRCYYLEM-UHFFFAOYSA-N 0.000 description 29
- 239000011734 sodium Substances 0.000 description 29
- ASOQFOGGRQMLJO-OUKQBFOZSA-N 4-o-tert-butyl 1-o-methyl (e)-3-hydroxy-2-phenylmethoxybut-2-enedioate Chemical compound CC(C)(C)OC(=O)C(/O)=C(C(=O)OC)\OCC1=CC=CC=C1 ASOQFOGGRQMLJO-OUKQBFOZSA-N 0.000 description 28
- 241000712461 unidentified influenza virus Species 0.000 description 27
- 239000000706 filtrate Substances 0.000 description 26
- WQDUMFSSJAZKTM-UHFFFAOYSA-N sodium methoxide Substances [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 22
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 22
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
- 230000000840 anti-viral effect Effects 0.000 description 22
- 239000003480 eluent Substances 0.000 description 22
- 239000010410 layer Substances 0.000 description 22
- 229910052938 sodium sulfate Inorganic materials 0.000 description 22
- 235000011152 sodium sulphate Nutrition 0.000 description 22
- 239000003814 drug Substances 0.000 description 21
- 238000004896 high resolution mass spectrometry Methods 0.000 description 21
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 21
- 238000000746 purification Methods 0.000 description 21
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 20
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 20
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 18
- 229940079593 drug Drugs 0.000 description 18
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 18
- 238000003786 synthesis reaction Methods 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 17
- 238000001914 filtration Methods 0.000 description 17
- QNEIZSSWCVSZOS-UHFFFAOYSA-N methyl 2-phenylmethoxyacetate Chemical compound COC(=O)COCC1=CC=CC=C1 QNEIZSSWCVSZOS-UHFFFAOYSA-N 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 15
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 239000006260 foam Substances 0.000 description 15
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 239000002253 acid Substances 0.000 description 14
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 14
- 125000006280 2-bromobenzyl group Chemical group [H]C1=C([H])C(Br)=C(C([H])=C1[H])C([H])([H])* 0.000 description 13
- 229910004298 SiO 2 Inorganic materials 0.000 description 13
- 239000012230 colorless oil Substances 0.000 description 13
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 13
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 229910019142 PO4 Inorganic materials 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 12
- 235000021317 phosphate Nutrition 0.000 description 12
- 238000010898 silica gel chromatography Methods 0.000 description 12
- FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 11
- CNHTVOASBDBLDV-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)phenyl]acetonitrile Chemical compound ClC1=CC=CC=C1C1=CC=CC=C1CC#N CNHTVOASBDBLDV-UHFFFAOYSA-N 0.000 description 11
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 11
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 11
- 102000028391 RNA cap binding Human genes 0.000 description 11
- 108091000106 RNA cap binding Proteins 0.000 description 11
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical class C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 11
- 239000003443 antiviral agent Substances 0.000 description 11
- 235000010357 aspartame Nutrition 0.000 description 11
- 230000008901 benefit Effects 0.000 description 11
- 239000010452 phosphate Substances 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 11
- 239000002911 sialidase inhibitor Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 10
- BLMPQCLKSJDIBT-UHFFFAOYSA-N 9-hydroxy-2-methyl-6-[(2-phenylphenyl)methyl]-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound N=1C(=O)C(O)=C2C(=O)N(C)CCN2C=1CC1=CC=CC=C1C1=CC=CC=C1 BLMPQCLKSJDIBT-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 150000001408 amides Chemical class 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- HUDUYUNMIUMUJD-UHFFFAOYSA-N 2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1(C=2C=CC(Cl)=CC=2)CCCC1 HUDUYUNMIUMUJD-UHFFFAOYSA-N 0.000 description 9
- GWQLMSTUGJQEAW-UHFFFAOYSA-N 2-[tert-butyl(dimethyl)silyl]oxy-n-methylethanamine Chemical compound CNCCO[Si](C)(C)C(C)(C)C GWQLMSTUGJQEAW-UHFFFAOYSA-N 0.000 description 9
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- 230000037396 body weight Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 230000010076 replication Effects 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 8
- MKYVWVIBNRPTTC-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-2-[(2-phenylphenyl)methyl]-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1=CC=CC=C1C1=CC=CC=C1 MKYVWVIBNRPTTC-UHFFFAOYSA-N 0.000 description 8
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 230000008020 evaporation Effects 0.000 description 8
- 238000003818 flash chromatography Methods 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- POVUFAWFKMLJMM-UHFFFAOYSA-N tert-butyl 2-[(2,3-dichlorophenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1=CC=CC(Cl)=C1Cl POVUFAWFKMLJMM-UHFFFAOYSA-N 0.000 description 8
- VVEDYRAHNYIUKL-UHFFFAOYSA-N tert-butyl 4-oxo-5-phenylmethoxy-2-[(2-phenylphenyl)methyl]-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1=CC=CC=C1C1=CC=CC=C1 VVEDYRAHNYIUKL-UHFFFAOYSA-N 0.000 description 8
- OMURGRVZFYQLBG-UHFFFAOYSA-N 2-[(2,3-dichlorophenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1=CC=CC(Cl)=C1Cl OMURGRVZFYQLBG-UHFFFAOYSA-N 0.000 description 7
- RTGXLBAVGIYVCT-UHFFFAOYSA-N 2-[(2-bromophenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1=CC=CC=C1Br RTGXLBAVGIYVCT-UHFFFAOYSA-N 0.000 description 7
- OEWOLGUPPDCDFP-UHFFFAOYSA-N 2-[(2-bromophenyl)methyl]-n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1=CC=CC=C1Br OEWOLGUPPDCDFP-UHFFFAOYSA-N 0.000 description 7
- YBXSVQTZLVNAKE-UHFFFAOYSA-N 2-[[1-(2,5-dichlorophenyl)cyclopentyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1(C=2C(=CC=C(Cl)C=2)Cl)CCCC1 YBXSVQTZLVNAKE-UHFFFAOYSA-N 0.000 description 7
- 229940123424 Neuraminidase inhibitor Drugs 0.000 description 7
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 7
- 125000004093 cyano group Chemical group *C#N 0.000 description 7
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 7
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 7
- 231100000673 dose–response relationship Toxicity 0.000 description 7
- 239000000890 drug combination Substances 0.000 description 7
- 150000002430 hydrocarbons Chemical group 0.000 description 7
- 229940098779 methanesulfonic acid Drugs 0.000 description 7
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 7
- SOVRTLIVEBRPIV-UHFFFAOYSA-N tert-butyl 2-[(5-methoxy-2-phenylphenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound C=1C(OC)=CC=C(C=2C=CC=CC=2)C=1CC(N=C1C(=O)OC(C)(C)C)=NC(O)=C1OCC1=CC=CC=C1 SOVRTLIVEBRPIV-UHFFFAOYSA-N 0.000 description 7
- UOUFRTFWWBCVPV-UHFFFAOYSA-N tert-butyl 4-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CC1)n1c(=O)[nH]c2ccsc2c1=O UOUFRTFWWBCVPV-UHFFFAOYSA-N 0.000 description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 7
- 230000009385 viral infection Effects 0.000 description 7
- QRQXOUFVHQDYJS-UHFFFAOYSA-N (1-phenylcyclopentyl)methyl methanesulfonate Chemical compound C=1C=CC=CC=1C1(COS(=O)(=O)C)CCCC1 QRQXOUFVHQDYJS-UHFFFAOYSA-N 0.000 description 6
- SCKXKZOLUSWBRC-UHFFFAOYSA-N 1-(2,5-dichlorophenyl)cyclopentane-1-carbaldehyde Chemical compound ClC1=CC=C(Cl)C(C2(CCCC2)C=O)=C1 SCKXKZOLUSWBRC-UHFFFAOYSA-N 0.000 description 6
- ZEPPSIVTTCKELV-UHFFFAOYSA-N 1-(2,5-dichlorophenyl)cyclopentane-1-carbonitrile Chemical compound ClC1=CC=C(Cl)C(C2(CCCC2)C#N)=C1 ZEPPSIVTTCKELV-UHFFFAOYSA-N 0.000 description 6
- KZCVVVIPPHGCOH-UHFFFAOYSA-N 1-phenylcyclopentane-1-carbaldehyde Chemical compound C=1C=CC=CC=1C1(C=O)CCCC1 KZCVVVIPPHGCOH-UHFFFAOYSA-N 0.000 description 6
- GDXMFFGTPGAGGX-UHFFFAOYSA-N 1-phenylcyclopentane-1-carbonitrile Chemical compound C=1C=CC=CC=1C1(C#N)CCCC1 GDXMFFGTPGAGGX-UHFFFAOYSA-N 0.000 description 6
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 6
- MSILGXYVRBMZJA-UHFFFAOYSA-N 2-(1-phenylcyclopentyl)acetonitrile Chemical compound C=1C=CC=CC=1C1(CC#N)CCCC1 MSILGXYVRBMZJA-UHFFFAOYSA-N 0.000 description 6
- NSTFJPUNOFYVCC-UHFFFAOYSA-N 2-(8-phenyl-1,4-dioxaspiro[4.5]decan-8-yl)acetonitrile Chemical compound C1CC(CC#N)(C=2C=CC=CC=2)CCC21OCCO2 NSTFJPUNOFYVCC-UHFFFAOYSA-N 0.000 description 6
- LDTHZLHPAOSVKH-UHFFFAOYSA-N 2-[1-(2,5-dichlorophenyl)cyclopentyl]ethanimidamide;hydrochloride Chemical compound Cl.C=1C(Cl)=CC=C(Cl)C=1C1(CC(=N)N)CCCC1 LDTHZLHPAOSVKH-UHFFFAOYSA-N 0.000 description 6
- VSJLEBWBSJMLND-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)phenyl]-n'-hydroxyethanimidamide Chemical compound ONC(=N)CC1=CC=CC=C1C1=CC=CC=C1Cl VSJLEBWBSJMLND-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- 229940123734 Endonuclease inhibitor Drugs 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 6
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 6
- NZIDEIRWYRJYAI-UHFFFAOYSA-N (1-phenylcyclohexyl)methanol Chemical compound C=1C=CC=CC=1C1(CO)CCCCC1 NZIDEIRWYRJYAI-UHFFFAOYSA-N 0.000 description 5
- NLHJLQZXHOLSBX-UHFFFAOYSA-N 1-(4-bromophenyl)cyclopentane-1-carbonitrile Chemical compound C1=CC(Br)=CC=C1C1(C#N)CCCC1 NLHJLQZXHOLSBX-UHFFFAOYSA-N 0.000 description 5
- CHNMUXHAGUGWJF-UHFFFAOYSA-N 1-phenylcyclohexane-1-carbaldehyde Chemical compound C=1C=CC=CC=1C1(C=O)CCCCC1 CHNMUXHAGUGWJF-UHFFFAOYSA-N 0.000 description 5
- QTZSJWWGPBHVRZ-UHFFFAOYSA-N 2-(1-phenylcyclohexyl)acetonitrile Chemical compound C=1C=CC=CC=1C1(CC#N)CCCCC1 QTZSJWWGPBHVRZ-UHFFFAOYSA-N 0.000 description 5
- CDGLONLCRQZFNU-UHFFFAOYSA-N 2-(2,3-dichlorophenyl)ethanimidamide;hydrochloride Chemical compound Cl.NC(=N)CC1=CC=CC(Cl)=C1Cl CDGLONLCRQZFNU-UHFFFAOYSA-N 0.000 description 5
- BVCOJESIQPNOIF-UHFFFAOYSA-N 2-(2-bromophenyl)acetonitrile Chemical compound BrC1=CC=CC=C1CC#N BVCOJESIQPNOIF-UHFFFAOYSA-N 0.000 description 5
- GTVFCTLUZMPIJI-UHFFFAOYSA-N 2-(2-bromophenyl)ethanimidamide;hydrochloride Chemical compound Cl.NC(=N)CC1=CC=CC=C1Br GTVFCTLUZMPIJI-UHFFFAOYSA-N 0.000 description 5
- CRGVWXVIMVMUDM-UHFFFAOYSA-N 2-(3-phenylpyridin-2-yl)acetonitrile Chemical compound N#CCC1=NC=CC=C1C1=CC=CC=C1 CRGVWXVIMVMUDM-UHFFFAOYSA-N 0.000 description 5
- YSCYSJMOXDKGQZ-UHFFFAOYSA-N 2-(3-phenylpyridin-2-yl)ethanimidamide Chemical compound NC(=N)CC1=NC=CC=C1C1=CC=CC=C1 YSCYSJMOXDKGQZ-UHFFFAOYSA-N 0.000 description 5
- IGHVHNVXANBJNH-UHFFFAOYSA-N 2-(4-oxo-1-phenylcyclohexyl)acetonitrile Chemical compound C1CC(=O)CCC1(CC#N)C1=CC=CC=C1 IGHVHNVXANBJNH-UHFFFAOYSA-N 0.000 description 5
- JGMHBULHZNOKMR-UHFFFAOYSA-N 2-methyl-2-(trifluoromethyl)-1,3-oxazolidine Chemical compound FC(F)(F)C1(C)NCCO1 JGMHBULHZNOKMR-UHFFFAOYSA-N 0.000 description 5
- JCAQKHMWADMPHS-UHFFFAOYSA-N 2-methyl-4-oxo-1h-pyrimidine-6-carboxylic acid Chemical compound CC1=NC(=O)C=C(C(O)=O)N1 JCAQKHMWADMPHS-UHFFFAOYSA-N 0.000 description 5
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 5
- GDMNROWUYDCXRE-UHFFFAOYSA-N 3-methyl-3-phenylbutanenitrile Chemical compound N#CCC(C)(C)C1=CC=CC=C1 GDMNROWUYDCXRE-UHFFFAOYSA-N 0.000 description 5
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 5
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 5
- 208000036142 Viral infection Diseases 0.000 description 5
- JIKYMOWXZLUFEQ-UHFFFAOYSA-N [1-(2,5-dichlorophenyl)cyclopentyl]methanol Chemical compound C=1C(Cl)=CC=C(Cl)C=1C1(CO)CCCC1 JIKYMOWXZLUFEQ-UHFFFAOYSA-N 0.000 description 5
- CSDXGWKBNIWHDT-UHFFFAOYSA-N [1-(2,5-dichlorophenyl)cyclopentyl]methyl methanesulfonate Chemical compound C=1C(Cl)=CC=C(Cl)C=1C1(COS(=O)(=O)C)CCCC1 CSDXGWKBNIWHDT-UHFFFAOYSA-N 0.000 description 5
- DHYFIHUDHWJOEK-UHFFFAOYSA-N [1-(4-bromophenyl)cyclopentyl]methanol Chemical compound C=1C=C(Br)C=CC=1C1(CO)CCCC1 DHYFIHUDHWJOEK-UHFFFAOYSA-N 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 5
- GKSQPBCSWMRKDG-UHFFFAOYSA-N acetic acid;2-(2-phenylphenyl)ethanimidamide Chemical compound CC(O)=O.NC(=N)CC1=CC=CC=C1C1=CC=CC=C1 GKSQPBCSWMRKDG-UHFFFAOYSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 150000003840 hydrochlorides Chemical class 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- OWEZOVIIGPRTHA-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-2-[(3-phenylpyridin-2-yl)methyl]-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1=NC=CC=C1C1=CC=CC=C1 OWEZOVIIGPRTHA-UHFFFAOYSA-N 0.000 description 5
- RYSACCAHHUEAEN-UHFFFAOYSA-N n-[1-amino-2-[2-(2-chlorophenyl)phenyl]ethylidene]acetamide Chemical compound CC(=O)NC(=N)CC1=CC=CC=C1C1=CC=CC=C1Cl RYSACCAHHUEAEN-UHFFFAOYSA-N 0.000 description 5
- SHZWGJCCRNFXCB-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-4-oxo-n-(1-phenylethyl)-5-phenylmethoxy-1h-pyrimidine-6-carboxamide Chemical compound C=1C=CC=CC=1C(C)N(CCO[Si](C)(C)C(C)(C)C)C(=O)C(C(=C(O)N=1)OCC=2C=CC=CC=2)=NC=1CC1(C=2C=CC(Cl)=CC=2)CCCC1 SHZWGJCCRNFXCB-UHFFFAOYSA-N 0.000 description 5
- NNUFPNIVWSBZNU-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-n-methyl-4-oxo-5-phenylmethoxy-2-[(2-phenylphenyl)methyl]-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO[Si](C)(C)C(C)(C)C)C)=NC=1CC1=CC=CC=C1C1=CC=CC=C1 NNUFPNIVWSBZNU-UHFFFAOYSA-N 0.000 description 5
- BRVFSWBAAITLFH-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]aniline Chemical compound CC(C)(C)[Si](C)(C)OCCNC1=CC=CC=C1 BRVFSWBAAITLFH-UHFFFAOYSA-N 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000001932 seasonal effect Effects 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- ZFXUVEHSCSRWRF-UHFFFAOYSA-N tert-butyl 2-[(2-bromophenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1=CC=CC=C1Br ZFXUVEHSCSRWRF-UHFFFAOYSA-N 0.000 description 5
- HRQGSTNROKTAAB-UHFFFAOYSA-N tert-butyl 2-[[1-(2,5-dichlorophenyl)cyclopentyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1(C=2C(=CC=C(Cl)C=2)Cl)CCCC1 HRQGSTNROKTAAB-UHFFFAOYSA-N 0.000 description 5
- OYAYTQKSBZPBSX-UHFFFAOYSA-N (1-naphthalen-2-ylcyclopentyl)methyl methanesulfonate Chemical compound C=1C=C2C=CC=CC2=CC=1C1(COS(=O)(=O)C)CCCC1 OYAYTQKSBZPBSX-UHFFFAOYSA-N 0.000 description 4
- SSBGLUVSZQPEOF-UHFFFAOYSA-N (1-phenylcyclohexyl)methyl methanesulfonate Chemical compound C=1C=CC=CC=1C1(COS(=O)(=O)C)CCCCC1 SSBGLUVSZQPEOF-UHFFFAOYSA-N 0.000 description 4
- FAUPBSCUZRPAIV-UHFFFAOYSA-N (2-methyl-2-phenylpropyl) methanesulfonate Chemical compound CS(=O)(=O)OCC(C)(C)C1=CC=CC=C1 FAUPBSCUZRPAIV-UHFFFAOYSA-N 0.000 description 4
- MPKBPMYJCDNVEF-UHFFFAOYSA-N (4-bromothiophen-3-yl)methanol Chemical compound OCC1=CSC=C1Br MPKBPMYJCDNVEF-UHFFFAOYSA-N 0.000 description 4
- KDWQLICBSFIDRM-UHFFFAOYSA-N 1,1,1-trifluoropropane Chemical compound CCC(F)(F)F KDWQLICBSFIDRM-UHFFFAOYSA-N 0.000 description 4
- ICRAWERFPUHELI-UHFFFAOYSA-N 1-(4-bromophenyl)cyclopentane-1-carbaldehyde Chemical compound C1=CC(Br)=CC=C1C1(C=O)CCCC1 ICRAWERFPUHELI-UHFFFAOYSA-N 0.000 description 4
- SFLBUWNIEZIWSB-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]cyclopentane-1-carbaldehyde Chemical compound C1=CC(C(F)(F)F)=CC=C1C1(C=O)CCCC1 SFLBUWNIEZIWSB-UHFFFAOYSA-N 0.000 description 4
- HDLXZRNBHPORST-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]cyclopentane-1-carbonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1C1(C#N)CCCC1 HDLXZRNBHPORST-UHFFFAOYSA-N 0.000 description 4
- ROCIEOUYIMZFGP-UHFFFAOYSA-N 1-naphthalen-2-ylcyclopentane-1-carbonitrile Chemical compound C=1C=C2C=CC=CC2=CC=1C1(C#N)CCCC1 ROCIEOUYIMZFGP-UHFFFAOYSA-N 0.000 description 4
- UHVOPTGFTCRQSQ-UHFFFAOYSA-N 2-(1,1,1-trifluoropropan-2-ylamino)ethanol Chemical compound FC(F)(F)C(C)NCCO UHVOPTGFTCRQSQ-UHFFFAOYSA-N 0.000 description 4
- AJTLJILQHLRKAC-UHFFFAOYSA-N 2-(1-naphthalen-2-ylcyclopentyl)acetonitrile Chemical compound C=1C=C2C=CC=CC2=CC=1C1(CC#N)CCCC1 AJTLJILQHLRKAC-UHFFFAOYSA-N 0.000 description 4
- IZAIMJVWYJKDFF-UHFFFAOYSA-N 2-(1-naphthalen-2-ylcyclopentyl)ethanimidamide;hydrochloride Chemical compound Cl.C=1C=C2C=CC=CC2=CC=1C1(CC(=N)N)CCCC1 IZAIMJVWYJKDFF-UHFFFAOYSA-N 0.000 description 4
- GXIWMXAAPLZOBY-UHFFFAOYSA-N 2-(1-phenylethylamino)ethanol Chemical compound OCCNC(C)C1=CC=CC=C1 GXIWMXAAPLZOBY-UHFFFAOYSA-N 0.000 description 4
- AQXXSQWNVCHBPR-UHFFFAOYSA-N 2-(2-methyl-2-phenylpropyl)-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound C=1C=CC=CC=1C(C)(C)CC(N=C1C(O)=O)=NC(O)=C1OCC1=CC=CC=C1 AQXXSQWNVCHBPR-UHFFFAOYSA-N 0.000 description 4
- URJIMSMUIDZLTA-UHFFFAOYSA-N 2-(2-phenylphenyl)propanenitrile Chemical compound N#CC(C)C1=CC=CC=C1C1=CC=CC=C1 URJIMSMUIDZLTA-UHFFFAOYSA-N 0.000 description 4
- ROWYSCPBAGGPEZ-UHFFFAOYSA-N 2-(2-phenylphenyl)propanimidamide;hydrochloride Chemical compound Cl.NC(=N)C(C)C1=CC=CC=C1C1=CC=CC=C1 ROWYSCPBAGGPEZ-UHFFFAOYSA-N 0.000 description 4
- KSIUCNSNELRLQL-UHFFFAOYSA-N 2-(4-bromothiophen-3-yl)acetonitrile Chemical compound BrC1=CSC=C1CC#N KSIUCNSNELRLQL-UHFFFAOYSA-N 0.000 description 4
- CHUIFAFFCFPALU-UHFFFAOYSA-N 2-(4-phenylthiophen-3-yl)acetonitrile Chemical compound N#CCC1=CSC=C1C1=CC=CC=C1 CHUIFAFFCFPALU-UHFFFAOYSA-N 0.000 description 4
- KDSSSIOQFZSUSO-UHFFFAOYSA-N 2-(4-phenylthiophen-3-yl)ethanimidamide;hydrochloride Chemical compound Cl.NC(=N)CC1=CSC=C1C1=CC=CC=C1 KDSSSIOQFZSUSO-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RCNJTGHVXVEOKN-UHFFFAOYSA-N 2-[(2,3-dichlorophenyl)methyl]-n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1=CC=CC(Cl)=C1Cl RCNJTGHVXVEOKN-UHFFFAOYSA-N 0.000 description 4
- KEGBVYJMPIYKEQ-UHFFFAOYSA-N 2-[1-(4-bromophenyl)cyclopentyl]acetonitrile Chemical compound C1=CC(Br)=CC=C1C1(CC#N)CCCC1 KEGBVYJMPIYKEQ-UHFFFAOYSA-N 0.000 description 4
- FBSYJMMTEKHEAL-UHFFFAOYSA-N 2-[2-(2,3-difluorophenyl)phenyl]acetonitrile Chemical compound FC1=CC=CC(C=2C(=CC=CC=2)CC#N)=C1F FBSYJMMTEKHEAL-UHFFFAOYSA-N 0.000 description 4
- FWZXPZJOELALMT-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)phenyl]ethanimidamide;hydrochloride Chemical compound Cl.NC(=N)CC1=CC=CC=C1C1=CC=CC=C1Cl FWZXPZJOELALMT-UHFFFAOYSA-N 0.000 description 4
- YHPUKWSIJCYFLM-UHFFFAOYSA-N 2-o-tert-butyl 1-o-methyl oxalate Chemical compound COC(=O)C(=O)OC(C)(C)C YHPUKWSIJCYFLM-UHFFFAOYSA-N 0.000 description 4
- YTFXBGFBUGEUCB-UHFFFAOYSA-N 3-bromo-4-(chloromethyl)thiophene Chemical compound ClCC1=CSC=C1Br YTFXBGFBUGEUCB-UHFFFAOYSA-N 0.000 description 4
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 4
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- XUOLTZBENDBPDQ-UHFFFAOYSA-N 4-oxo-2-[(1-phenylcyclohexyl)methyl]-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1(C=2C=CC=CC=2)CCCCC1 XUOLTZBENDBPDQ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 4
- 241000712431 Influenza A virus Species 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- NWMZFDWGBCYBJA-UHFFFAOYSA-N [1-[4-(trifluoromethyl)phenyl]cyclopentyl]methanol Chemical compound C=1C=C(C(F)(F)F)C=CC=1C1(CO)CCCC1 NWMZFDWGBCYBJA-UHFFFAOYSA-N 0.000 description 4
- LCKUWDYMVYQQCU-UHFFFAOYSA-N [1-[4-(trifluoromethyl)phenyl]cyclopentyl]methyl methanesulfonate Chemical compound C=1C=C(C(F)(F)F)C=CC=1C1(COS(=O)(=O)C)CCCC1 LCKUWDYMVYQQCU-UHFFFAOYSA-N 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 4
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- WXCNIHQUZGGPAJ-UHFFFAOYSA-N ethyl 2-cyano-2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate Chemical compound C1CC(=C(C#N)C(=O)OCC)CCC21OCCO2 WXCNIHQUZGGPAJ-UHFFFAOYSA-N 0.000 description 4
- IFOOQGCWMLSFQB-UHFFFAOYSA-N ethyl 3-indol-1-yl-3-methylbutanoate Chemical compound C1=CC=C2N(C(C)(C)CC(=O)OCC)C=CC2=C1 IFOOQGCWMLSFQB-UHFFFAOYSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 229960003752 oseltamivir Drugs 0.000 description 4
- NENPYTRHICXVCS-YNEHKIRRSA-N oseltamivir acid Chemical compound CCC(CC)O[C@@H]1C=C(C(O)=O)C[C@H](N)[C@H]1NC(C)=O NENPYTRHICXVCS-YNEHKIRRSA-N 0.000 description 4
- 238000002953 preparative HPLC Methods 0.000 description 4
- 230000000069 prophylactic effect Effects 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- WVSVFXFAFPIHSY-UHFFFAOYSA-N tert-butyl 2-[[1-(4-bromophenyl)cyclopentyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1(C=2C=CC(Br)=CC=2)CCCC1 WVSVFXFAFPIHSY-UHFFFAOYSA-N 0.000 description 4
- PFEFZDQGHVBHAZ-UHFFFAOYSA-N tert-butyl 4-oxo-2-[(1-phenylcyclohexyl)methyl]-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1(C=2C=CC=CC=2)CCCCC1 PFEFZDQGHVBHAZ-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- RLNNOWYDUKFUFJ-UHFFFAOYSA-N (1-naphthalen-2-ylcyclopentyl)methanol Chemical compound C=1C=C2C=CC=CC2=CC=1C1(CO)CCCC1 RLNNOWYDUKFUFJ-UHFFFAOYSA-N 0.000 description 3
- WJMWSPUOZRYMJD-UHFFFAOYSA-N (1-phenylcyclopentyl)methanol Chemical compound C=1C=CC=CC=1C1(CO)CCCC1 WJMWSPUOZRYMJD-UHFFFAOYSA-N 0.000 description 3
- RRCMGJCFMJBHQC-UHFFFAOYSA-N (2-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1Cl RRCMGJCFMJBHQC-UHFFFAOYSA-N 0.000 description 3
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 3
- AUXIEQKHXAYAHG-UHFFFAOYSA-N 1-phenylcyclohexane-1-carbonitrile Chemical compound C=1C=CC=CC=1C1(C#N)CCCCC1 AUXIEQKHXAYAHG-UHFFFAOYSA-N 0.000 description 3
- VENLCWMUKMKXEA-UHFFFAOYSA-N 2-(naphthalen-1-ylmethyl)-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound OC(=O)C=1N=C(CC=2C3=CC=CC=C3C=CC=2)NC(=O)C=1OCC1=CC=CC=C1 VENLCWMUKMKXEA-UHFFFAOYSA-N 0.000 description 3
- BUEBLYWWHDMQKK-UHFFFAOYSA-N 2-[(2-bromophenyl)methyl]-n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)N(CCO[Si](C)(C)C(C)(C)C)C(C)C)NC=1CC1=CC=CC=C1Br BUEBLYWWHDMQKK-UHFFFAOYSA-N 0.000 description 3
- MBWMQVJGGRPLAF-UHFFFAOYSA-N 2-[1-(4-chlorophenyl)cyclopentyl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1C1(CC#N)CCCC1 MBWMQVJGGRPLAF-UHFFFAOYSA-N 0.000 description 3
- BKUIDGOTIQPEQN-UHFFFAOYSA-N 2-[2-(2,3-difluorophenyl)phenyl]ethanimidamide;hydrochloride Chemical compound Cl.NC(=N)CC1=CC=CC=C1C1=CC=CC(F)=C1F BKUIDGOTIQPEQN-UHFFFAOYSA-N 0.000 description 3
- IANIEJYWVZTFHA-UHFFFAOYSA-N 2-naphthalen-1-ylethanimidamide;hydrochloride Chemical compound Cl.C1=CC=C2C(CC(=N)N)=CC=CC2=C1 IANIEJYWVZTFHA-UHFFFAOYSA-N 0.000 description 3
- IVYMIRMKXZAHRV-UHFFFAOYSA-N 4-chlorophenylacetonitrile Chemical compound ClC1=CC=C(CC#N)C=C1 IVYMIRMKXZAHRV-UHFFFAOYSA-N 0.000 description 3
- NNRSWOGAACVMRX-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-2-[(3-phenylpyridin-2-yl)methyl]-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1=NC=CC=C1C1=CC=CC=C1 NNRSWOGAACVMRX-UHFFFAOYSA-N 0.000 description 3
- LQBCOOHJJBGAGG-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-2-[1-(2-phenylphenyl)ethyl]-1h-pyrimidine-6-carboxylic acid Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1C(C)C(NC1=O)=NC(C(O)=O)=C1OCC1=CC=CC=C1 LQBCOOHJJBGAGG-UHFFFAOYSA-N 0.000 description 3
- VDAADDFCENCTNE-UHFFFAOYSA-N 6-[(2,3-dichlorophenyl)methyl]-9-phenylmethoxy-2-propan-2-yl-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C2C(=O)N(C(C)C)CCN2C=1CC1=CC=CC(Cl)=C1Cl VDAADDFCENCTNE-UHFFFAOYSA-N 0.000 description 3
- OUGOXGUDEFDKKI-UHFFFAOYSA-N 6-[[1-(4-bromophenyl)cyclopentyl]methyl]-9-phenylmethoxy-2-propan-2-yl-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C2C(=O)N(C(C)C)CCN2C=1CC1(C=2C=CC(Br)=CC=2)CCCC1 OUGOXGUDEFDKKI-UHFFFAOYSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 102000005348 Neuraminidase Human genes 0.000 description 3
- 108010006232 Neuraminidase Proteins 0.000 description 3
- CLSAHANEATTWHW-UHFFFAOYSA-N OCCN(C(=O)C1=NC(N(C(=C1OCC1=CC=CC=C1)O)C)C1=C(C=CC=C1)C1=CC=CC=C1)C Chemical compound OCCN(C(=O)C1=NC(N(C(=C1OCC1=CC=CC=C1)O)C)C1=C(C=CC=C1)C1=CC=CC=C1)C CLSAHANEATTWHW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 108020005161 RNA Caps Proteins 0.000 description 3
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 3
- 229940124639 Selective inhibitor Drugs 0.000 description 3
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 3
- 108020000999 Viral RNA Proteins 0.000 description 3
- NKCRWCXWGYLXGQ-UHFFFAOYSA-N [1-(4-bromophenyl)cyclopentyl]methyl methanesulfonate Chemical compound C=1C=C(Br)C=CC=1C1(COS(=O)(=O)C)CCCC1 NKCRWCXWGYLXGQ-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 3
- 229960003805 amantadine Drugs 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- 229940125400 channel inhibitor Drugs 0.000 description 3
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 208000037797 influenza A Diseases 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- ZKBMNBLAOMYOHJ-VXGBXAGGSA-N methyl (1r,2s)-2-phenylcyclopentane-1-carboxylate Chemical compound COC(=O)[C@@H]1CCC[C@@H]1C1=CC=CC=C1 ZKBMNBLAOMYOHJ-VXGBXAGGSA-N 0.000 description 3
- YXSARWFSYZHULU-UHFFFAOYSA-N methyl 2-(trifluoromethylsulfonyloxy)cyclopentene-1-carboxylate Chemical compound COC(=O)C1=C(OS(=O)(=O)C(F)(F)F)CCC1 YXSARWFSYZHULU-UHFFFAOYSA-N 0.000 description 3
- ZRXXWPHNSUNQEZ-UHFFFAOYSA-N methyl 2-phenylcyclopentene-1-carboxylate Chemical compound C1CCC(C(=O)OC)=C1C1=CC=CC=C1 ZRXXWPHNSUNQEZ-UHFFFAOYSA-N 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- NAMAHOPLNMCDSC-UHFFFAOYSA-N n'-hydroxy-2-(3-phenylpyridin-2-yl)ethanimidamide Chemical compound ONC(=N)CC1=NC=CC=C1C1=CC=CC=C1 NAMAHOPLNMCDSC-UHFFFAOYSA-N 0.000 description 3
- BGNRGXLRTHQBIV-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-(naphthalen-1-ylmethyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound OCCN(C(C)C)C(=O)C=1N=C(CC=2C3=CC=CC=C3C=CC=2)NC(=O)C=1OCC1=CC=CC=C1 BGNRGXLRTHQBIV-UHFFFAOYSA-N 0.000 description 3
- YIIVVAXFKIGZGX-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-2-[1-(2-phenylphenyl)ethyl]-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound OCCN(C(C)C)C(=O)C=1N=C(C(C)C=2C(=CC=CC=2)C=2C=CC=CC=2)NC(=O)C=1OCC1=CC=CC=C1 YIIVVAXFKIGZGX-UHFFFAOYSA-N 0.000 description 3
- FEXMQFSIBBVFIG-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-1-phenylethanamine Chemical compound CC(C)(C)[Si](C)(C)OCCNC(C)C1=CC=CC=C1 FEXMQFSIBBVFIG-UHFFFAOYSA-N 0.000 description 3
- LCQXDQRSSJZECW-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxo-2-[(1-phenylcyclohexyl)methyl]-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO[Si](C)(C)C(C)(C)C)C(C)C)=NC=1CC1(C=2C=CC=CC=2)CCCCC1 LCQXDQRSSJZECW-UHFFFAOYSA-N 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- HKSQZEGSMBFHGC-UHFFFAOYSA-N pyrimidine-4-carboxamide Chemical compound NC(=O)C1=CC=NC=N1 HKSQZEGSMBFHGC-UHFFFAOYSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229960000329 ribavirin Drugs 0.000 description 3
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 3
- 229960000888 rimantadine Drugs 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000029812 viral genome replication Effects 0.000 description 3
- YOWQODGCIURGAO-CMDGGOBGSA-N (e)-2-hydroxy-3-phenylmethoxybut-2-enedioic acid Chemical compound OC(=O)C(\O)=C(C(O)=O)/OCC1=CC=CC=C1 YOWQODGCIURGAO-CMDGGOBGSA-N 0.000 description 2
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 2
- UTOAJPCXCJNPNA-UHFFFAOYSA-N 1-(4-chlorophenyl)cyclopentane-1-carbaldehyde Chemical compound C1=CC(Cl)=CC=C1C1(C=O)CCCC1 UTOAJPCXCJNPNA-UHFFFAOYSA-N 0.000 description 2
- PWMWNFMRSKOCEY-UHFFFAOYSA-N 1-Phenyl-1,2-ethanediol Chemical compound OCC(O)C1=CC=CC=C1 PWMWNFMRSKOCEY-UHFFFAOYSA-N 0.000 description 2
- CZLINJDTCHACEH-UHFFFAOYSA-N 2-(2,3-dichlorophenyl)acetonitrile Chemical compound ClC1=CC=CC(CC#N)=C1Cl CZLINJDTCHACEH-UHFFFAOYSA-N 0.000 description 2
- RLUBZPCKOYSHNQ-UHFFFAOYSA-N 2-(2,5-dichlorophenyl)acetonitrile Chemical compound ClC1=CC=C(Cl)C(CC#N)=C1 RLUBZPCKOYSHNQ-UHFFFAOYSA-N 0.000 description 2
- VSSZEBGUCILFSV-UHFFFAOYSA-N 2-(2-bromo-5-methoxyphenyl)acetonitrile Chemical compound COC1=CC=C(Br)C(CC#N)=C1 VSSZEBGUCILFSV-UHFFFAOYSA-N 0.000 description 2
- LXSBAIGHHOJQAX-UHFFFAOYSA-N 2-(2-methoxyphenyl)ethanimidamide;hydrochloride Chemical compound Cl.COC1=CC=CC=C1CC(N)=N LXSBAIGHHOJQAX-UHFFFAOYSA-N 0.000 description 2
- MFHFWRBXPQDZSA-UHFFFAOYSA-N 2-(4-bromophenyl)acetonitrile Chemical compound BrC1=CC=C(CC#N)C=C1 MFHFWRBXPQDZSA-UHFFFAOYSA-N 0.000 description 2
- UXVUQYUPHQYWLH-UHFFFAOYSA-N 2-(8-phenyl-1,4-dioxaspiro[4.5]decan-8-yl)ethanimidamide Chemical compound C1CC(CC(=N)N)(C=2C=CC=CC=2)CCC21OCCO2 UXVUQYUPHQYWLH-UHFFFAOYSA-N 0.000 description 2
- ULPGKXWODVWLMP-UHFFFAOYSA-N 2-[(1-naphthalen-2-ylcyclopentyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1(C=2C=C3C=CC=CC3=CC=2)CCCC1 ULPGKXWODVWLMP-UHFFFAOYSA-N 0.000 description 2
- ZTSVHMDIMMQLSP-UHFFFAOYSA-N 2-[(2,6-dichlorophenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)O)NC=1CC1=C(Cl)C=CC=C1Cl ZTSVHMDIMMQLSP-UHFFFAOYSA-N 0.000 description 2
- ORKWQPUBEOIVJF-UHFFFAOYSA-N 2-[(5-methoxy-2-phenylphenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound C=1C(OC)=CC=C(C=2C=CC=CC=2)C=1CC(N=C1C(O)=O)=NC(O)=C1OCC1=CC=CC=C1 ORKWQPUBEOIVJF-UHFFFAOYSA-N 0.000 description 2
- ZSCVMEDDRCPART-UHFFFAOYSA-N 2-[1-(4-methylphenyl)cyclopentyl]ethanimidamide Chemical compound C1=CC(C)=CC=C1C1(CC(N)=N)CCCC1 ZSCVMEDDRCPART-UHFFFAOYSA-N 0.000 description 2
- NCDPKVXNGAPFPF-UHFFFAOYSA-N 2-[1-[3,5-bis(trifluoromethyl)phenyl]cyclopentyl]acetonitrile Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2(CC#N)CCCC2)=C1 NCDPKVXNGAPFPF-UHFFFAOYSA-N 0.000 description 2
- QNKOCFJZJWOXDE-UHFFFAOYSA-N 2-[4-(trifluoromethyl)phenyl]acetonitrile Chemical compound FC(F)(F)C1=CC=C(CC#N)C=C1 QNKOCFJZJWOXDE-UHFFFAOYSA-N 0.000 description 2
- ZVSCENGNXWPDPL-UHFFFAOYSA-N 2-methyl-2-phenylpropan-1-ol Chemical compound OCC(C)(C)C1=CC=CC=C1 ZVSCENGNXWPDPL-UHFFFAOYSA-N 0.000 description 2
- LPCWDVLDJVZIHA-UHFFFAOYSA-N 2-naphthalen-2-ylacetonitrile Chemical compound C1=CC=CC2=CC(CC#N)=CC=C21 LPCWDVLDJVZIHA-UHFFFAOYSA-N 0.000 description 2
- PMLKMTAKGVWNJP-UHFFFAOYSA-N 3-indol-1-yl-3-methylbutanimidamide;hydrochloride Chemical compound Cl.C1=CC=C2N(C(C)(CC(N)=N)C)C=CC2=C1 PMLKMTAKGVWNJP-UHFFFAOYSA-N 0.000 description 2
- KDNYCTPSPZHJQF-UHFFFAOYSA-N 3-phenylbutan-2-ol Chemical compound CC(O)C(C)C1=CC=CC=C1 KDNYCTPSPZHJQF-UHFFFAOYSA-N 0.000 description 2
- NNXRJYFQRYRBQZ-UHFFFAOYSA-N 4-oxo-2-[(1-phenylcyclopentyl)methyl]-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1(C=2C=CC=CC=2)CCCC1 NNXRJYFQRYRBQZ-UHFFFAOYSA-N 0.000 description 2
- SBSFFROVIBCLNP-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-2-[[1-[4-(trifluoromethyl)phenyl]cyclopentyl]methyl]-1h-pyrimidine-6-carboxylic acid Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)O)=NC=1CC1(C=2C=CC(=CC=2)C(F)(F)F)CCCC1 SBSFFROVIBCLNP-UHFFFAOYSA-N 0.000 description 2
- QXFNFVRKUOTYAG-UHFFFAOYSA-N 4-oxo-5-phenylmethoxy-2-pyridin-2-yl-1h-pyrimidine-6-carboxylic acid Chemical compound OC(=O)C1=NC(C=2N=CC=CC=2)=NC(O)=C1OCC1=CC=CC=C1 QXFNFVRKUOTYAG-UHFFFAOYSA-N 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 2
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 108090000862 Ion Channels Proteins 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 2
- YSJJYGWMTGJNGH-UHFFFAOYSA-N carbon dioxide;ethane-1,2-diol Chemical compound O=C=O.OCCO YSJJYGWMTGJNGH-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229940111134 coxibs Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 2
- 229940043264 dodecyl sulfate Drugs 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- WCQOBLXWLRDEQA-UHFFFAOYSA-N ethanimidamide;hydrochloride Chemical class Cl.CC(N)=N WCQOBLXWLRDEQA-UHFFFAOYSA-N 0.000 description 2
- QOSWIWRLRTVQKM-UHFFFAOYSA-N ethyl 2-cyano-2-(8-phenyl-1,4-dioxaspiro[4.5]decan-8-yl)acetate Chemical compound C1CC(C(C#N)C(=O)OCC)(C=2C=CC=CC=2)CCC21OCCO2 QOSWIWRLRTVQKM-UHFFFAOYSA-N 0.000 description 2
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- FOLBQETVQNWYHV-UHFFFAOYSA-N n'-hydroxy-2-(8-phenyl-1,4-dioxaspiro[4.5]decan-8-yl)ethanimidamide Chemical compound C1CC(CC(=N)NO)(C=2C=CC=CC=2)CCC21OCCO2 FOLBQETVQNWYHV-UHFFFAOYSA-N 0.000 description 2
- CHUFQWKWQMAYKE-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-[(1-naphthalen-2-ylcyclopentyl)methyl]-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1(C=2C=C3C=CC=CC3=CC=2)CCCC1 CHUFQWKWQMAYKE-UHFFFAOYSA-N 0.000 description 2
- TVKWIZHDNDIVMG-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-oxo-2-[(1-phenylcyclohexyl)methyl]-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1(C=2C=CC=CC=2)CCCCC1 TVKWIZHDNDIVMG-UHFFFAOYSA-N 0.000 description 2
- OKUVQKOHUKKNOZ-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-oxo-2-[(4-oxo-1-phenylcyclohexyl)methyl]-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1(C=2C=CC=CC=2)CCC(=O)CC1 OKUVQKOHUKKNOZ-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 201000010740 swine influenza Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- SPAYOBGXIOAZEV-UHFFFAOYSA-N tert-butyl 2-(naphthalen-1-ylmethyl)-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound CC(C)(C)OC(=O)C=1N=C(CC=2C3=CC=CC=C3C=CC=2)NC(=O)C=1OCC1=CC=CC=C1 SPAYOBGXIOAZEV-UHFFFAOYSA-N 0.000 description 2
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000006490 viral transcription Effects 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- TYIKXPOMOYDGCS-UHFFFAOYSA-N (2,3-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1Cl TYIKXPOMOYDGCS-UHFFFAOYSA-N 0.000 description 1
- SZYXKFKWFYUOGZ-UHFFFAOYSA-N (2,3-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1F SZYXKFKWFYUOGZ-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RMGYQBHKEWWTOY-UHFFFAOYSA-N (3,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(F)=C1 RMGYQBHKEWWTOY-UHFFFAOYSA-N 0.000 description 1
- CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
- CEBAHYWORUOILU-UHFFFAOYSA-N (4-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=C(C#N)C=C1 CEBAHYWORUOILU-UHFFFAOYSA-N 0.000 description 1
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 1
- IVUHTLFKBDDICS-UHFFFAOYSA-N (4-methylsulfanylphenyl)boronic acid Chemical compound CSC1=CC=C(B(O)O)C=C1 IVUHTLFKBDDICS-UHFFFAOYSA-N 0.000 description 1
- IAEUFBDMVKQCLU-UHFFFAOYSA-N (4-propan-2-ylphenyl)boronic acid Chemical compound CC(C)C1=CC=C(B(O)O)C=C1 IAEUFBDMVKQCLU-UHFFFAOYSA-N 0.000 description 1
- QTENCRUTCHPVIE-MDZDMXLPSA-N (E)-2-hydroxy-4-methoxy-4-oxo-3-phenylmethoxybut-2-enoic acid Chemical compound COC(/C(=C(/C(=O)O)\O)/OCC1=CC=CC=C1)=O QTENCRUTCHPVIE-MDZDMXLPSA-N 0.000 description 1
- NLEIDKFNCMKNIF-MDZDMXLPSA-N (E)-3-phenylmethoxybut-2-en-2-ol Chemical compound C(C1=CC=CC=C1)O\C(\C)=C(/C)\O NLEIDKFNCMKNIF-MDZDMXLPSA-N 0.000 description 1
- GRZHHTYDZVRPIC-UHFFFAOYSA-N (benzyloxy)acetic acid Chemical compound OC(=O)COCC1=CC=CC=C1 GRZHHTYDZVRPIC-UHFFFAOYSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- CMHPUBKZZPSUIQ-UHFFFAOYSA-N 1,3-benzodioxol-5-ylboronic acid Chemical compound OB(O)C1=CC=C2OCOC2=C1 CMHPUBKZZPSUIQ-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical group C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- IBODDUNKEPPBKW-UHFFFAOYSA-N 1,5-dibromopentane Chemical compound BrCCCCCBr IBODDUNKEPPBKW-UHFFFAOYSA-N 0.000 description 1
- BYEMOPAVGULHAT-UHFFFAOYSA-N 1-(2-methylphenyl)propan-1-ol Chemical compound CCC(O)C1=CC=CC=C1C BYEMOPAVGULHAT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- XVNUHSLYUDNRPB-UHFFFAOYSA-N 1-chloro-4-cyclopentylbenzene Chemical compound C1=CC(Cl)=CC=C1C1CCCC1 XVNUHSLYUDNRPB-UHFFFAOYSA-N 0.000 description 1
- ONYSYALUMOGBKJ-UHFFFAOYSA-N 1-methyl-6-oxopyrimidine-4-carboxylic acid Chemical compound CN1C=NC(C(O)=O)=CC1=O ONYSYALUMOGBKJ-UHFFFAOYSA-N 0.000 description 1
- DKKRQSHSFCLKNG-UHFFFAOYSA-N 1-naphthalen-2-ylcyclopentane-1-carbaldehyde Chemical compound C=1C=C2C=CC=CC2=CC=1C1(C=O)CCCC1 DKKRQSHSFCLKNG-UHFFFAOYSA-N 0.000 description 1
- OXZKZIVFCBHOLA-UHFFFAOYSA-N 1H-pteridine-2,4-dione pyrido[2,3-b]pyrazine Chemical class N1=CC=NC2=CC=CN=C21.C1=CN=C2C(=O)NC(=O)NC2=N1 OXZKZIVFCBHOLA-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 1
- ZKDNBOAOTQCXLM-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;potassium;sodium Chemical class [Na].[K].OC(=O)C(O)C(O)C(O)=O ZKDNBOAOTQCXLM-UHFFFAOYSA-N 0.000 description 1
- LSWVQNOEFSGKRJ-UHFFFAOYSA-N 2-(1-phenylcyclohexyl)ethanimidamide Chemical compound C=1C=CC=CC=1C1(CC(=N)N)CCCCC1 LSWVQNOEFSGKRJ-UHFFFAOYSA-N 0.000 description 1
- ZQAPMQNYBFIJJR-UHFFFAOYSA-N 2-(1-phenylcyclopentyl)ethanimidamide;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C1(CC(=N)N)CCCC1 ZQAPMQNYBFIJJR-UHFFFAOYSA-N 0.000 description 1
- AOMMAALHPAGRKP-UHFFFAOYSA-N 2-(2-bromo-5-methoxyphenyl)ethanimidamide Chemical compound COC1=CC=C(Br)C(CC(N)=N)=C1 AOMMAALHPAGRKP-UHFFFAOYSA-N 0.000 description 1
- ADODIWDJDMWOEF-UHFFFAOYSA-N 2-(2-bromo-5-methoxyphenyl)ethanimidamide;hydrochloride Chemical compound Cl.COC1=CC=C(Br)C(CC(N)=N)=C1 ADODIWDJDMWOEF-UHFFFAOYSA-N 0.000 description 1
- CAKUAVIXSOZILM-UHFFFAOYSA-N 2-(2-bromophenyl)propanenitrile Chemical compound N#CC(C)C1=CC=CC=C1Br CAKUAVIXSOZILM-UHFFFAOYSA-N 0.000 description 1
- FPSGTRJUQLYLHE-UHFFFAOYSA-N 2-(2-iodophenyl)acetonitrile Chemical compound IC1=CC=CC=C1CC#N FPSGTRJUQLYLHE-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- PEGHZBVRVYBTCU-UHFFFAOYSA-N 2-[(2,6-dichlorophenyl)methyl]-n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)N(CCO)C(C)C)NC=1CC1=C(Cl)C=CC=C1Cl PEGHZBVRVYBTCU-UHFFFAOYSA-N 0.000 description 1
- KQRXAGHJMZJQAL-UHFFFAOYSA-N 2-[1-(2,5-dichlorophenyl)cyclopentyl]acetonitrile Chemical compound ClC1=CC=C(Cl)C(C2(CC#N)CCCC2)=C1 KQRXAGHJMZJQAL-UHFFFAOYSA-N 0.000 description 1
- ZAJCNIHBBMCVKH-UHFFFAOYSA-N 2-[1-[4-(trifluoromethyl)phenyl]cyclopentyl]acetonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1C1(CC#N)CCCC1 ZAJCNIHBBMCVKH-UHFFFAOYSA-N 0.000 description 1
- QRHJBGUPZQUKHL-UHFFFAOYSA-N 2-[2-(2,3-difluorophenyl)phenyl]ethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1C1=CC=CC(F)=C1F QRHJBGUPZQUKHL-UHFFFAOYSA-N 0.000 description 1
- WEIOLIAGTFINKF-UHFFFAOYSA-N 2-[[1-(2,5-dichlorophenyl)cyclopentyl]methyl]-5-phenylmethoxy-1H-pyrimidin-6-one Chemical compound C1CCC(C1)(CC2=NC=C(C(=O)N2)OCC3=CC=CC=C3)C4=C(C=CC(=C4)Cl)Cl WEIOLIAGTFINKF-UHFFFAOYSA-N 0.000 description 1
- LPLRVONTLVIGJQ-UHFFFAOYSA-N 2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-5-phenylmethoxy-1H-pyrimidin-6-one Chemical compound C(C1=CC=CC=C1)OC=1C=NC(=NC=1O)CC1(CCCC1)C1=CC=C(C=C1)Cl LPLRVONTLVIGJQ-UHFFFAOYSA-N 0.000 description 1
- KZEIKZOIZDVRCA-UHFFFAOYSA-N 2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-n-(2-hydroxyethyl)-4-oxo-n-(1-phenylethyl)-5-phenylmethoxy-1h-pyrimidine-6-carboxamide Chemical compound C=1C=CC=CC=1C(C)N(CCO)C(=O)C(C(=C(O)N=1)OCC=2C=CC=CC=2)=NC=1CC1(C=2C=CC(Cl)=CC=2)CCCC1 KZEIKZOIZDVRCA-UHFFFAOYSA-N 0.000 description 1
- QAXVCFHHWOWDIQ-UHFFFAOYSA-N 2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-n-(2-hydroxyethyl)-4-oxo-n-phenyl-5-phenylmethoxy-1h-pyrimidine-6-carboxamide Chemical compound C=1C=CC=CC=1N(CCO)C(=O)C(C(=C(O)N=1)OCC=2C=CC=CC=2)=NC=1CC1(C=2C=CC(Cl)=CC=2)CCCC1 QAXVCFHHWOWDIQ-UHFFFAOYSA-N 0.000 description 1
- ADBHIDDMCREJHH-UHFFFAOYSA-N 2-[[2-(2,3-difluorophenyl)phenyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylic acid Chemical compound N1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)O)N=C1CC1=CC=CC=C1C1=CC=CC(F)=C1F ADBHIDDMCREJHH-UHFFFAOYSA-N 0.000 description 1
- ZIUIVSJIRVGLRJ-UHFFFAOYSA-N 2-[[2-(2,3-difluorophenyl)phenyl]methyl]-n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)N(CCO)C(C)C)N=C1CC1=CC=CC=C1C1=CC=CC(F)=C1F ZIUIVSJIRVGLRJ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UXUZARPLRQRNNX-DXTOWSMRSA-N 2-amino-9-[(2r,3r,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1F UXUZARPLRQRNNX-DXTOWSMRSA-N 0.000 description 1
- OGHAROSJZRTIOK-KQYNXXCUSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methylpurin-9-ium-6-olate Chemical group C12=NC(N)=NC([O-])=C2N(C)C=[N+]1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-N 0.000 description 1
- MWGATWIBSKHFMR-UHFFFAOYSA-N 2-anilinoethanol Chemical compound OCCNC1=CC=CC=C1 MWGATWIBSKHFMR-UHFFFAOYSA-N 0.000 description 1
- HTFXWAOSQODIBI-UHFFFAOYSA-N 2-benzyl-1,3-dihydropyrrolo[3,4-c]pyridine Chemical compound C1C2=CC=NC=C2CN1CC1=CC=CC=C1 HTFXWAOSQODIBI-UHFFFAOYSA-N 0.000 description 1
- LAXBNTIAOJWAOP-UHFFFAOYSA-N 2-chlorobiphenyl Chemical group ClC1=CC=CC=C1C1=CC=CC=C1 LAXBNTIAOJWAOP-UHFFFAOYSA-N 0.000 description 1
- KDRUIMNNZBMLJR-UHFFFAOYSA-N 2-isopropylaminoethylamine Chemical compound CC(C)NCCN KDRUIMNNZBMLJR-UHFFFAOYSA-N 0.000 description 1
- QHTJSSMHBLGUHV-UHFFFAOYSA-N 2-methylbutan-2-ylbenzene Chemical compound CCC(C)(C)C1=CC=CC=C1 QHTJSSMHBLGUHV-UHFFFAOYSA-N 0.000 description 1
- CDBDBWCUGHXFTN-UHFFFAOYSA-N 2-methylpyrimidine-4-carboxylic acid Chemical compound CC1=NC=CC(C(O)=O)=N1 CDBDBWCUGHXFTN-UHFFFAOYSA-N 0.000 description 1
- OQRMWUNUKVUHQO-UHFFFAOYSA-N 2-naphthalen-1-ylacetonitrile Chemical compound C1=CC=C2C(CC#N)=CC=CC2=C1 OQRMWUNUKVUHQO-UHFFFAOYSA-N 0.000 description 1
- 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
- UUIMDJFBHNDZOW-UHFFFAOYSA-N 2-tert-butylpyridine Chemical compound CC(C)(C)C1=CC=CC=N1 UUIMDJFBHNDZOW-UHFFFAOYSA-N 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-M 3-carboxynaphthalen-2-olate Chemical compound C1=CC=C2C=C(C([O-])=O)C(O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-M 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- OVUUOLJZWZVAOH-UHFFFAOYSA-N 3-indol-1-yl-3-methylbutanimidamide Chemical compound C1=CC=C2N(C(C)(CC(N)=N)C)C=CC2=C1 OVUUOLJZWZVAOH-UHFFFAOYSA-N 0.000 description 1
- COUZAGXGXFTWTH-UHFFFAOYSA-N 3-methyl-3-phenylbutanal Chemical compound O=CCC(C)(C)C1=CC=CC=C1 COUZAGXGXFTWTH-UHFFFAOYSA-N 0.000 description 1
- STXMJIGNQBRHOV-UHFFFAOYSA-N 3-methyl-3-phenylbutanimidamide Chemical compound NC(=N)CC(C)(C)C1=CC=CC=C1 STXMJIGNQBRHOV-UHFFFAOYSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- APBIZVFQQBCAAT-UHFFFAOYSA-N 4-bromothiophene-3-carboxylic acid Chemical compound OC(=O)C1=CSC=C1Br APBIZVFQQBCAAT-UHFFFAOYSA-N 0.000 description 1
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- MTEVDAFXFLGBKO-UHFFFAOYSA-N 5-phenylmethoxy-2-[[1-[4-(trifluoromethyl)phenyl]cyclopentyl]methyl]-1H-pyrimidin-6-one Chemical compound C(C1=CC=CC=C1)OC=1C=NC(=NC=1O)CC1(CCCC1)C1=CC=C(C=C1)C(F)(F)F MTEVDAFXFLGBKO-UHFFFAOYSA-N 0.000 description 1
- BUHZROAJJAJSCO-UHFFFAOYSA-N 6-[(2,3-dichlorophenyl)methyl]-9-hydroxy-2-propan-2-yl-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound N=1C(=O)C(O)=C2C(=O)N(C(C)C)CCN2C=1CC1=CC=CC(Cl)=C1Cl BUHZROAJJAJSCO-UHFFFAOYSA-N 0.000 description 1
- JYQBBGREQSZLKS-UHFFFAOYSA-N 6-[[1-(2,5-dichlorophenyl)cyclopentyl]methyl]-9-phenylmethoxy-2-propan-2-yl-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C2C(=O)N(C(C)C)CCN2C=1CC1(C=2C(=CC=C(Cl)C=2)Cl)CCCC1 JYQBBGREQSZLKS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- NGPVZFGEMDNOTA-UHFFFAOYSA-N 8-phenyl-1,4-dioxaspiro[4.5]decane-8-carbonitrile Chemical compound C1CC(C#N)(C=2C=CC=CC=2)CCC21OCCO2 NGPVZFGEMDNOTA-UHFFFAOYSA-N 0.000 description 1
- LDJQSBPSMOULIB-UHFFFAOYSA-N 9-hydroxy-2-propan-2-yl-6-[[1-[4-(trifluoromethyl)phenyl]cyclopentyl]methyl]-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound N=1C(=O)C(O)=C2C(=O)N(C(C)C)CCN2C=1CC1(C=2C=CC(=CC=2)C(F)(F)F)CCCC1 LDJQSBPSMOULIB-UHFFFAOYSA-N 0.000 description 1
- ZLPRLOFJFQZXSH-UHFFFAOYSA-N 9-hydroxy-6-[[2-(4-methylsulfanylphenyl)phenyl]methyl]-2-propan-2-yl-3,4-dihydropyrazino[1,2-c]pyrimidine-1,8-dione Chemical compound C1=CC(SC)=CC=C1C1=CC=CC=C1CC1=NC(=O)C(O)=C2N1CCN(C(C)C)C2=O ZLPRLOFJFQZXSH-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000701242 Adenoviridae Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241001533362 Astroviridae Species 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000776207 Bornaviridae Species 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- CXPHOOYQDOPNSI-UHFFFAOYSA-N C(C)(C)(C)OC(=O)C=1N=CNC(C=1)=O Chemical compound C(C)(C)(C)OC(=O)C=1N=CNC(C=1)=O CXPHOOYQDOPNSI-UHFFFAOYSA-N 0.000 description 1
- SJURLVIEIKTKGD-UHFFFAOYSA-N CC(C)(C)OC(=O)C(=CC(=O)OC)O Chemical compound CC(C)(C)OC(=O)C(=CC(=O)OC)O SJURLVIEIKTKGD-UHFFFAOYSA-N 0.000 description 1
- MIJXRNJAVATQKE-UHFFFAOYSA-N CN(CCO)C(C1=NC(CC(C=CC=C2)=C2C2=CC=CC=C2)=NC(O)=C1)=O Chemical compound CN(CCO)C(C1=NC(CC(C=CC=C2)=C2C2=CC=CC=C2)=NC(O)=C1)=O MIJXRNJAVATQKE-UHFFFAOYSA-N 0.000 description 1
- 229940124638 COX inhibitor Drugs 0.000 description 1
- 241000714198 Caliciviridae Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 241000104338 Delitschia confertaspora Species 0.000 description 1
- 241001533413 Deltavirus Species 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 1
- 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- SIXHCCPAJIVTOY-UHFFFAOYSA-N Flutimide Natural products CC(C)CC1=NC(=CC(C)C)C(=O)N(O)C1=O SIXHCCPAJIVTOY-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 229940099797 HIV integrase inhibitor Drugs 0.000 description 1
- 241000700739 Hepadnaviridae Species 0.000 description 1
- 241001122120 Hepeviridae Species 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical group C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001661732 Isavirus Species 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229940122142 Lipoxygenase inhibitor Drugs 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IAPKUSBKIGQOIE-UHFFFAOYSA-N O.O.O.O.[K].[Na].C(C(O)C(O)C(=O)O)(=O)O Chemical compound O.O.O.O.[K].[Na].C(C(O)C(O)C(=O)O)(=O)O IAPKUSBKIGQOIE-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000713112 Orthobunyavirus Species 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 1
- 241000150218 Orthonairovirus Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical group C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 101150020891 PRKCA gene Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 241000701945 Parvoviridae Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000713137 Phlebovirus Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 241001631648 Polyomaviridae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- 241000700625 Poxviridae Species 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
- 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical group C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001605014 Rabovirus Species 0.000 description 1
- 241000702247 Reoviridae Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 240000001068 Thogoto virus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- WNPVHSUQBZYKDI-UHFFFAOYSA-N [(e)-[1-amino-2-(8-phenyl-1,4-dioxaspiro[4.5]decan-8-yl)ethylidene]amino] acetate Chemical compound C1CC(CC(/N)=N/OC(=O)C)(C=2C=CC=CC=2)CCC21OCCO2 WNPVHSUQBZYKDI-UHFFFAOYSA-N 0.000 description 1
- JPVGEFSYKNYYAU-UHFFFAOYSA-N [1-(4-chlorophenyl)cyclopentyl]methanol Chemical compound C=1C=C(Cl)C=CC=1C1(CO)CCCC1 JPVGEFSYKNYYAU-UHFFFAOYSA-N 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- HFJFKDJWYFXWCV-UHFFFAOYSA-N acetyl 3,3-dimethylbutanoate Chemical group CC(=O)OC(=O)CC(C)(C)C HFJFKDJWYFXWCV-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 108700010877 adenoviridae proteins Proteins 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N anhydrous methyl chloride Natural products ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- OISFUZRUIGGTSD-LJTMIZJLSA-N azane;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol Chemical compound N.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO OISFUZRUIGGTSD-LJTMIZJLSA-N 0.000 description 1
- OQKFGIANPCRSSK-UHFFFAOYSA-N azanium;methanol;acetate Chemical compound [NH4+].OC.CC([O-])=O OQKFGIANPCRSSK-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000003556 cannabinoid 2 receptor agonist Substances 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940090805 clavulanate Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960005168 croscarmellose Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- XZWQKJXJNKYMAP-UHFFFAOYSA-N cyclohexen-1-ylboronic acid Chemical compound OB(O)C1=CCCCC1 XZWQKJXJNKYMAP-UHFFFAOYSA-N 0.000 description 1
- 239000003260 cyclooxygenase 1 inhibitor Substances 0.000 description 1
- BALGDZWGNCXXES-UHFFFAOYSA-N cyclopentane;propanoic acid Chemical compound CCC(O)=O.C1CCCC1 BALGDZWGNCXXES-UHFFFAOYSA-N 0.000 description 1
- VELDYOPRLMJFIK-UHFFFAOYSA-N cyclopentanecarbaldehyde Chemical compound O=CC1CCCC1 VELDYOPRLMJFIK-UHFFFAOYSA-N 0.000 description 1
- SVPZJHKVRMRREG-UHFFFAOYSA-N cyclopentanecarbonitrile Chemical compound N#CC1CCCC1 SVPZJHKVRMRREG-UHFFFAOYSA-N 0.000 description 1
- 150000001940 cyclopentanes Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
- ZAYMRPIJNLRXJH-UHFFFAOYSA-N dichloromethane methanesulfonyl chloride Chemical compound CS(=O)(=O)Cl.ClCCl ZAYMRPIJNLRXJH-UHFFFAOYSA-N 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SPCNPOWOBZQWJK-UHFFFAOYSA-N dimethoxy-(2-propan-2-ylsulfanylethylsulfanyl)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)SCCSC(C)C SPCNPOWOBZQWJK-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 229940112141 dry powder inhaler Drugs 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
- JJTJZFLRKYYGGS-UHFFFAOYSA-N ethoxyethane;methylsulfinylmethane Chemical compound CS(C)=O.CCOCC JJTJZFLRKYYGGS-UHFFFAOYSA-N 0.000 description 1
- UIWISFUVNHCOBJ-UHFFFAOYSA-N ethyl 2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate Chemical compound C1CC(=CC(=O)OCC)CCC21OCCO2 UIWISFUVNHCOBJ-UHFFFAOYSA-N 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- UTXVCHVLDOLVPC-UHFFFAOYSA-N ethyl 3-methylbut-2-enoate Chemical compound CCOC(=O)C=C(C)C UTXVCHVLDOLVPC-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- SIXHCCPAJIVTOY-UITAMQMPSA-N flutimide Chemical compound CC(C)CC1=N\C(=C/C(C)C)C(=O)N(O)C1=O SIXHCCPAJIVTOY-UITAMQMPSA-N 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003084 hiv integrase inhibitor Substances 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000005828 hydrofluoroalkanes Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229940126181 ion channel inhibitor Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940099584 lactobionate Drugs 0.000 description 1
- JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- KKMJGUDIUVOQTI-STWSTGMMSA-N methyl (2s)-2-(1-adamantylmethylamino)-3-(4h-imidazol-4-yl)propanoate Chemical compound C([C@@H](C(=O)OC)NCC12CC3CC(CC(C3)C1)C2)C1C=NC=N1 KKMJGUDIUVOQTI-STWSTGMMSA-N 0.000 description 1
- WITYUUTUSPKOAB-UHFFFAOYSA-N methyl 2-methyl-2-phenylpropanoate Chemical compound COC(=O)C(C)(C)C1=CC=CC=C1 WITYUUTUSPKOAB-UHFFFAOYSA-N 0.000 description 1
- PZBBESSUKAHBHD-UHFFFAOYSA-N methyl 2-oxocyclopentane-1-carboxylate Chemical compound COC(=O)C1CCCC1=O PZBBESSUKAHBHD-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- HEUWTVFKSKHTRY-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-(2-methyl-2-phenylpropyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC(C)(C)C1=CC=CC=C1 HEUWTVFKSKHTRY-UHFFFAOYSA-N 0.000 description 1
- BLXMPECULGOGEN-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-oxo-5-phenylmethoxy-n-propan-2-yl-2-[(2-pyridin-4-ylphenyl)methyl]-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C(C)C)=NC=1CC1=CC=CC=C1C1=CC=NC=C1 BLXMPECULGOGEN-UHFFFAOYSA-N 0.000 description 1
- XAEOLGWURJHGLD-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-methyl-4-oxo-5-phenylmethoxy-2-[(2-phenylphenyl)methyl]-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO)C)=NC=1CC1=CC=CC=C1C1=CC=CC=C1 XAEOLGWURJHGLD-UHFFFAOYSA-N 0.000 description 1
- CFUPJKJDBLPWHY-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-2-[[1-(2,5-dichlorophenyl)cyclopentyl]methyl]-4-oxo-5-phenylmethoxy-n-propan-2-yl-1h-pyrimidine-6-carboxamide Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)N(CCO[Si](C)(C)C(C)(C)C)C(C)C)=NC=1CC1(C=2C(=CC=C(Cl)C=2)Cl)CCCC1 CFUPJKJDBLPWHY-UHFFFAOYSA-N 0.000 description 1
- QOQXXVZCAXFQRT-UHFFFAOYSA-N n-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-4-oxo-n-phenyl-5-phenylmethoxy-1h-pyrimidine-6-carboxamide Chemical compound C=1C=CC=CC=1N(CCO[Si](C)(C)C(C)(C)C)C(=O)C(C(=C(O)N=1)OCC=2C=CC=CC=2)=NC=1CC1(C=2C=CC(Cl)=CC=2)CCCC1 QOQXXVZCAXFQRT-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 108700013356 oplunofusp Proteins 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- CYJAWBVQRMVFEO-UHFFFAOYSA-N piperazine-2,6-dione Chemical group O=C1CNCC(=O)N1 CYJAWBVQRMVFEO-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000016833 positive regulation of signal transduction Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 1
- YPOXGDJGKBXRFP-UHFFFAOYSA-M pyrimidine-4-carboxylate Chemical compound [O-]C(=O)C1=CC=NC=N1 YPOXGDJGKBXRFP-UHFFFAOYSA-M 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- HELHAJAZNSDZJO-UHFFFAOYSA-L sodium tartrate Chemical compound [Na+].[Na+].[O-]C(=O)C(O)C(O)C([O-])=O HELHAJAZNSDZJO-UHFFFAOYSA-L 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- IGAZUJALTBQJBM-UHFFFAOYSA-N tert-butyl 2-(2-methyl-2-phenylpropyl)-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC(C)(C)C1=CC=CC=C1 IGAZUJALTBQJBM-UHFFFAOYSA-N 0.000 description 1
- MBSWKXRTNVVNKH-UHFFFAOYSA-N tert-butyl 2-[(2,6-dichlorophenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)OC(C)(C)C)NC=1CC1=C(Cl)C=CC=C1Cl MBSWKXRTNVVNKH-UHFFFAOYSA-N 0.000 description 1
- IQRKQWMOFMZOGL-UHFFFAOYSA-N tert-butyl 2-[(2-bromo-5-methoxyphenyl)methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound COC1=CC=C(Br)C(CC=2N=C(C(OCC=3C=CC=CC=3)=C(O)N=2)C(=O)OC(C)(C)C)=C1 IQRKQWMOFMZOGL-UHFFFAOYSA-N 0.000 description 1
- IGSFYLSWLBJJFS-UHFFFAOYSA-N tert-butyl 2-[[1-(4-chlorophenyl)cyclopentyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1(C=2C=CC(Cl)=CC=2)CCCC1 IGSFYLSWLBJJFS-UHFFFAOYSA-N 0.000 description 1
- ITEYHEDBAZJMAD-UHFFFAOYSA-N tert-butyl 2-[[2-(2,3-difluorophenyl)phenyl]methyl]-4-oxo-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N1C(=O)C(OCC=2C=CC=CC=2)=C(C(=O)OC(C)(C)C)N=C1CC1=CC=CC=C1C1=CC=CC(F)=C1F ITEYHEDBAZJMAD-UHFFFAOYSA-N 0.000 description 1
- ZETBECNZGHFDJE-UHFFFAOYSA-N tert-butyl 4-oxo-2-[(1-phenylcyclopentyl)methyl]-5-phenylmethoxy-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1(C=2C=CC=CC=2)CCCC1 ZETBECNZGHFDJE-UHFFFAOYSA-N 0.000 description 1
- AXQCAUINGWQGGJ-UHFFFAOYSA-N tert-butyl 4-oxo-5-phenylmethoxy-2-[(3-phenylpyridin-2-yl)methyl]-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1=NC=CC=C1C1=CC=CC=C1 AXQCAUINGWQGGJ-UHFFFAOYSA-N 0.000 description 1
- WRQBOSLEXQUCDR-UHFFFAOYSA-N tert-butyl 4-oxo-5-phenylmethoxy-2-[[1-[4-(trifluoromethyl)phenyl]cyclopentyl]methyl]-1h-pyrimidine-6-carboxylate Chemical compound N=1C(O)=C(OCC=2C=CC=CC=2)C(C(=O)OC(C)(C)C)=NC=1CC1(C=2C=CC(=CC=2)C(F)(F)F)CCCC1 WRQBOSLEXQUCDR-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 230000024275 uncoating of virus Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361750017P | 2013-01-08 | 2013-01-08 | |
| US61/750,017 | 2013-01-08 | ||
| PCT/EP2014/050165 WO2014108406A1 (en) | 2013-01-08 | 2014-01-07 | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20150103285A true KR20150103285A (ko) | 2015-09-09 |
Family
ID=50070507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020157021361A Withdrawn KR20150103285A (ko) | 2013-01-08 | 2014-01-07 | 피리미돈 유도체 및 바이러스 질환의 치료, 개선 또는 예방에서의 이의 용도 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9045486B2 (https=) |
| EP (1) | EP2943495B1 (https=) |
| JP (1) | JP2016518305A (https=) |
| KR (1) | KR20150103285A (https=) |
| CN (1) | CN104918942A (https=) |
| AR (1) | AR094378A1 (https=) |
| AU (1) | AU2014204889A1 (https=) |
| BR (1) | BR112015012693A2 (https=) |
| CA (1) | CA2894642A1 (https=) |
| CL (1) | CL2015001916A1 (https=) |
| CR (1) | CR20150337A (https=) |
| EA (1) | EA201591291A1 (https=) |
| HK (1) | HK1211286A1 (https=) |
| IL (1) | IL239656A0 (https=) |
| MA (1) | MA38323B1 (https=) |
| MX (1) | MX2015008293A (https=) |
| PE (1) | PE20151722A1 (https=) |
| PH (1) | PH12015501517A1 (https=) |
| SG (1) | SG11201503946UA (https=) |
| TW (1) | TW201443053A (https=) |
| WO (1) | WO2014108406A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL239682B (en) | 2013-01-08 | 2018-10-31 | Kalvista Pharmaceuticals Ltd | History of benzylamine and 2-(aminomethyl)pyridine |
| GB201300304D0 (en) | 2013-01-08 | 2013-02-20 | Kalvista Pharmaceuticals Ltd | Benzylamine derivatives |
| TWI636047B (zh) | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | 雜環衍生物 |
| WO2015038655A1 (en) | 2013-09-12 | 2015-03-19 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
| GB201421085D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | New enzyme inhibitors |
| GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| WO2016145103A1 (en) | 2015-03-11 | 2016-09-15 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
| BR112017022550B1 (pt) | 2015-04-28 | 2021-02-23 | Shionogi & Co., Ltd | derivados policíclicos de piridona substituída |
| MX394421B (es) | 2015-04-28 | 2025-03-24 | Shionogi & Co | Derivados de piridona policiclica sustituida y profarmaco de los mismos |
| TW201726678A (zh) | 2015-10-30 | 2017-08-01 | 赫孚孟拉羅股份公司 | 嘧啶酮衍生物及其於治療、改善或預防病毒性疾病之用途 |
| AU2016374416A1 (en) | 2015-12-15 | 2018-06-14 | Shionogi & Co., Ltd. | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
| WO2017109088A1 (en) | 2015-12-23 | 2017-06-29 | Savira Pharmaceuticals Gmbh | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| WO2017158147A1 (en) | 2016-03-18 | 2017-09-21 | Savira Pharmaceuticals Gmbh | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| WO2017158151A1 (en) | 2016-03-18 | 2017-09-21 | Savira Pharmaceuticals Gmbh | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| JP6961963B2 (ja) * | 2016-04-01 | 2021-11-05 | 三菱ケミカル株式会社 | フルフラールの製造方法 |
| EP3458455B1 (en) * | 2016-05-20 | 2021-06-16 | F. Hoffmann-La Roche AG | Novel pyrazine compounds with oxygen, sulfur and nitrogen linker for the treatment of infectious diseases |
| IL263235B (en) | 2016-05-31 | 2022-07-01 | Kalvista Pharmaceuticals Ltd | History of pyrazoles as plasma kallikrein inhibitors |
| GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
| GB201609603D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide |
| RU2727962C1 (ru) | 2016-08-10 | 2020-07-28 | Сионоги Энд Ко., Лтд. | Фармацевтические композиции, содержащие замещенные полициклические пиридоновые производные и их пролекарство |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| HUE057912T2 (hu) | 2017-11-29 | 2022-06-28 | Kalvista Pharmaceuticals Ltd | Plazma kallikrein inhibitort tartalmazó dózisformák |
| GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
| KR20230031990A (ko) | 2018-02-28 | 2023-03-07 | 노파르티스 아게 | 인플루엔자의 치료를 위한 오르토믹소바이러스 복제의 억제제로서의 10-(디(페닐)메틸)-4-히드록시-8,9,9a,10-테트라히드로-7h-피롤로[1',2':4,5]피라지노[1,2-b]피리다진-3,5-디온 유도체 및 관련 화합물 |
| WO2021028645A1 (en) | 2019-08-09 | 2021-02-18 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
| US20240228495A1 (en) * | 2020-03-25 | 2024-07-11 | Sri International | Tricyclic Inhibitors of Influenza Virus Endonuclease |
| EP4074317A1 (en) | 2021-04-14 | 2022-10-19 | Bayer AG | Phosphorus derivatives as novel sos1 inhibitors |
| WO2024061300A1 (en) * | 2022-09-22 | 2024-03-28 | Insilico Medicine Ip Limited | Inhibitors of trex1 and uses thereof |
| PE20251587A1 (es) | 2022-10-19 | 2025-06-16 | Astrazeneca Ab | 1,3,5-triazinas 2,4,6-trisustituidas como modulares de cx3cr1 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5475109A (en) | 1994-10-17 | 1995-12-12 | Merck & Co., Inc. | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease |
| WO2005087766A1 (en) | 2004-03-09 | 2005-09-22 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Hiv integrase inhibitors |
| CN101014572B (zh) | 2004-09-15 | 2011-07-06 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的氨基甲酰基吡啶酮衍生物 |
| TW200716632A (en) | 2005-05-16 | 2007-05-01 | Gilead Sciences Inc | Integrase inhibitor compounds |
| CA2616314A1 (en) * | 2005-07-27 | 2007-02-01 | Gilead Sciences, Inc. | Antiviral phosphonate conjugates for inhibition of hiv |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| US8835461B2 (en) | 2009-03-26 | 2014-09-16 | Shionogi & Co., Ltd. | Substituted 3-hydroxy-4-pyridone derivative |
| LT2444400T (lt) | 2009-06-15 | 2018-06-11 | Shionogi & Co., Ltd. | Pakeistasis policiklinis karbamoilpiridono darinys |
| WO2011000566A2 (en) | 2009-06-30 | 2011-01-06 | Savira Pharmaceuticals Gmbh | Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections |
| MX2013003139A (es) | 2010-09-24 | 2013-06-18 | Shionogi & Co | Profarmaco de derivado de carbamoilpiridona policiclica substituida. |
-
2014
- 2014-01-07 CN CN201480004139.1A patent/CN104918942A/zh active Pending
- 2014-01-07 KR KR1020157021361A patent/KR20150103285A/ko not_active Withdrawn
- 2014-01-07 HK HK15112095.2A patent/HK1211286A1/xx unknown
- 2014-01-07 US US14/149,284 patent/US9045486B2/en not_active Expired - Fee Related
- 2014-01-07 MA MA38323A patent/MA38323B1/fr unknown
- 2014-01-07 AR ARP140100051A patent/AR094378A1/es unknown
- 2014-01-07 EA EA201591291A patent/EA201591291A1/ru unknown
- 2014-01-07 MX MX2015008293A patent/MX2015008293A/es unknown
- 2014-01-07 WO PCT/EP2014/050165 patent/WO2014108406A1/en not_active Ceased
- 2014-01-07 BR BR112015012693A patent/BR112015012693A2/pt active Search and Examination
- 2014-01-07 PE PE2015001253A patent/PE20151722A1/es not_active Application Discontinuation
- 2014-01-07 CA CA2894642A patent/CA2894642A1/en not_active Abandoned
- 2014-01-07 SG SG11201503946UA patent/SG11201503946UA/en unknown
- 2014-01-07 AU AU2014204889A patent/AU2014204889A1/en not_active Abandoned
- 2014-01-07 JP JP2015551199A patent/JP2016518305A/ja active Pending
- 2014-01-07 EP EP14703275.9A patent/EP2943495B1/en not_active Not-in-force
- 2014-01-08 TW TW103100719A patent/TW201443053A/zh unknown
-
2015
- 2015-06-25 CR CR20150337A patent/CR20150337A/es unknown
- 2015-06-25 IL IL239656A patent/IL239656A0/en unknown
- 2015-07-03 PH PH12015501517A patent/PH12015501517A1/en unknown
- 2015-07-06 CL CL2015001916A patent/CL2015001916A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2015001916A1 (es) | 2016-01-22 |
| MX2015008293A (es) | 2016-06-02 |
| HK1211286A1 (en) | 2016-05-20 |
| SG11201503946UA (en) | 2015-09-29 |
| CR20150337A (es) | 2015-11-02 |
| AU2014204889A1 (en) | 2015-06-11 |
| EA201591291A1 (ru) | 2015-12-30 |
| EP2943495A1 (en) | 2015-11-18 |
| US9045486B2 (en) | 2015-06-02 |
| PH12015501517A1 (en) | 2015-11-09 |
| IL239656A0 (en) | 2015-08-31 |
| US20140194431A1 (en) | 2014-07-10 |
| MA38323A1 (fr) | 2017-02-28 |
| BR112015012693A2 (pt) | 2017-07-11 |
| AR094378A1 (es) | 2015-07-29 |
| EP2943495B1 (en) | 2016-12-28 |
| PE20151722A1 (es) | 2015-11-19 |
| TW201443053A (zh) | 2014-11-16 |
| JP2016518305A (ja) | 2016-06-23 |
| HK1212686A1 (en) | 2016-06-17 |
| MA38323B1 (fr) | 2018-05-31 |
| CA2894642A1 (en) | 2014-07-17 |
| CN104918942A (zh) | 2015-09-16 |
| WO2014108406A1 (en) | 2014-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20150103285A (ko) | 피리미돈 유도체 및 바이러스 질환의 치료, 개선 또는 예방에서의 이의 용도 | |
| CN103261167B (zh) | 取代的6，6-稠合含氮杂环化合物及其用途 | |
| CN105315285B (zh) | 2,4‑二取代7H‑吡咯并[2,3‑d]嘧啶衍生物、其制法与医药上的用途 | |
| KR20100138991A (ko) | 1-헤테로사이클릴-1,5-디하이드로-피라졸로[3,4-ｄ]피리미딘-4-온 유도체 및 ｐｄｅ９ａ 조절인자로서의 이의 용도 | |
| WO2016026445A1 (zh) | 作为fgfr激酶抑制剂的吲唑类化合物及其制备和应用 | |
| CN101636388A (zh) | 化合物637：作为pde4抑制剂的吡啶并嘧啶二酮 | |
| TW201506028A (zh) | １，２-雙取代雜環化合物 | |
| CN106220644A (zh) | 稠环嘧啶氨基衍生物﹑其制备方法、中间体、药物组合物及应用 | |
| WO2016173557A1 (zh) | 一类具有激酶抑制活性的化合物、制备方法和用途 | |
| JP2004523541A (ja) | 化合物 | |
| JP2009532401A (ja) | キナーゼ阻害剤としての３−置換Ｎ−（アリール−またはヘテロアリール）−ピラゾロ［１，５−ａ］ピリミジン | |
| TW202430164A (zh) | Pkmyt1抑制劑 | |
| TW202515544A (zh) | 作為ｃ－ｋｉｔ激酶抑制劑的醫藥化合物及組合物 | |
| TWI860797B (zh) | 新穎acc抑制劑 | |
| US9505758B2 (en) | Substituted 1,5-naphthyridines as endonuclease inhibitors | |
| TW201712011A (zh) | 作為ｂｅｔ家族溴結構域抑制劑之新穎吡啶吡酮 | |
| JP2022545007A (ja) | インターフェロン遺伝子の刺激因子ｓｔｉｎｇの単環式アゴニスト | |
| WO2023020209A1 (zh) | 含2-芳杂环取代的脲类化合物、其制备方法和用途 | |
| JP2018513153A (ja) | Ｐｄｅ１０インヒビターならびに関連する組成物および方法 | |
| JP2009532400A (ja) | キナーゼ阻害剤としての３−非置換Ｎ−（アリール−もしくはヘテロアリール）−ピラゾロ［１，５−ａ］ピリミジン | |
| CN115894376B (zh) | 一种芳香族酰胺类化合物、药物组合物及其用途 | |
| WO2018171740A1 (zh) | 一种哌尼诺安衍生物及其制备方法和应用 | |
| HK40081368B (zh) | 干扰素基因刺激物sting的单环激动剂 | |
| HK40081368A (en) | Monocyclic agonists of stimulator of interferon genes sting | |
| HK1212686B (en) | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20150806 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |